IBA acquires PETLinQ, takes on Hickey as prez of molecular tracers
IBA Molecular has acquired PETLinQ, an education and software technologies company serving the hospital, outpatient radiology, PET and nuclear medicine marketplace.
PETLinQ provides a suite of products and services for imaging, workflow and education for PET and PET/CT imaging centers, said the Louvain-la-Neuve, Belgium-based IBA.
IBA Molecular North America also announced that Michael Hickey, long-time executive with AstraZeneca, has been named president of IBA’s Molecular Tracers North America division. He will be based in Dulles, Va., and report to Renaud Dehareng, president of IBA Molecular Tracers Worldwide.
PETLinQ provides a suite of products and services for imaging, workflow and education for PET and PET/CT imaging centers, said the Louvain-la-Neuve, Belgium-based IBA.
IBA Molecular North America also announced that Michael Hickey, long-time executive with AstraZeneca, has been named president of IBA’s Molecular Tracers North America division. He will be based in Dulles, Va., and report to Renaud Dehareng, president of IBA Molecular Tracers Worldwide.